Jonathan Slonin - 05 Jul 2022 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Clinical Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
05 Jul 2022
Net transactions value
-$52,842
Form type
4
Filing time
07 Jul 2022, 19:04:19 UTC
Previous filing
08 Jun 2022
Next filing
05 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale $52,842 -924 -2.4% $57.19 37,387 05 Jul 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
F2 Includes 214 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022.